INDUSTRIES | CLINICAL STUDIES
Your Sites Juggle Fifteen Systems. Your Best Coordinators Keep Quitting. One Platform Fixes Both.
70% of research sites fight six or more logins per study1. Site staff turnover has doubled, reaching 61% at some site networks2. Every new system a sponsor bolts on makes both problems worse. Clinical-IQ™ replaces the stack with one platform your team controls.
THE PROBLEM
The Problems You Face Every Monday
Technology Overload Is Crushing Your Sites
Your Reality
EDC here. IVR there. Separate systems for eConsent, ePRO, safety letters, and payments. A different password for every study, from every sponsor.
Industry Reality
70% of sites report six or more logins per study. 55% rate sponsor technology setup and training as extremely or very burdensome. 67% say the burden is worse than five years ago.1
What Clinical-IQ™ Delivers:
-
One connected platform from recruitment through close-out. No fragmented systems
-
eConsent, eScreening, ePRO, scheduling, and participant correspondence in one system
-
Sites configure their own workflows without IT tickets
-
Site visits, home visits, and virtual visits managed in the same platform
Staff Turnover Is Eating Your Margins
Your Reality
You spend months training a coordinator on five sponsor systems. A signing bonus lures them away. You start over.
Industry Reality
Patient-facing site staff turnover jumped from a pre-pandemic range of 10 to 37% to a range of 35 to 61%2. A new hire needs 10 to 20 weeks before working independently2. Meanwhile, quarterly sponsor payment terms stretch site receivables from roughly 45 days to 137 days3. You are financing studies on credit while retraining the people who run them.
What We Deliver:
-
One platform to learn instead of fifteen
-
Workflow logic that lives in the system, not in the head of the coordinator who just resigned
-
Version control and approval flows that keep every study component traceable when staff turns over
Enrollment Failure Is Quietly Stifling Your Studies
Your Reality
Screening logs in spreadsheets. Referral campaigns you cannot track. No-shows you discover after the visit window closes.
Industry Reality
Only 31% of trials meet their enrollment goals4. In cancer trials, 19% of investigator sites enroll exactly one patient5. That single-patient site costs roughly $130,000 per enrolled patient. Top-performing sites do it for about $14,000.5
What Clinical-IQ™ Delivers:
-
eScreening with consistent data capture across every referral channel
-
Campaign analytics that show which recruitment spend actually enrolls patients
-
Automated reminders and notifications that cut no-shows
-
Real-time enrollment visibility across every site and every study
Why CROs and Research Sites Choose Frontier-IQ
Built by People Who Have Run Studies
Our team comes from inside clinical operations. We have lived through the 18-month implementations, the "seamless integrations" that needed an army of consultants, and the vendors who blame the site when the platform fails.
What We Do Differently
-
12-week implementations. Your team configures the platform, not consultant armies
-
White-label ready. CROs deploy under their own brand
-
Multi-study management, centralized or segmented by therapeutic area, phase, or geography
-
Frontier Cloud, Private Cloud, or On Premise hosting. Your call
Built For How Studies Actually Run
-
21 CFR Part 11 native, with support for 510(k) medical device studies
-
HIPAA and GDPR compliant, with data encrypted and never shared between studies or clients
-
AWS microservices with API-first integration to EHR, CTMS, and eConsent systems
OUR SOFTWARE
Three Platforms. One Integrated Solution.
Clinical-IQ™
The Study Engine
End-to-end lifecycle management. Recruitment and prescreening, enrollment and onboarding, ePRO data capture, close-out and sponsor reporting. Hybrid and decentralized trials without the integration circus.
Patient-Focus™
Retention That Holds
Participant engagement between visits. Automated reminders, omnichannel communication, and early warning on participants drifting toward dropout.
Data-IQ™
Intelligence Across Studies
Aggregate insights across trials and sites. Real-time operational dashboards, sponsor-ready reporting, and analytics that inform the next protocol, not just the last one.
References
1. Advarra. (2023). "New Clinical Trial Industry Survey Reveals Increased Burdens on Sites." https://www.advarra.com/news/new-clinical-trial-industry-survey-reveals-increased-burdens-on-sites/
2. Society for Clinical Research Sites. "Open Letter to Sponsor and CRO Colleagues Regarding Workforce Retention and Inflationary Pressures Affecting Clinical Trial Sites." https://myscrs.org/workforce-challenges-letter/
3. Society for Clinical Research Sites. "The Economic Impact of Payment Terms on Clinical Research Sites." https://myscrs.org/resources/economic-impact-site-payment-terms/
4. PMC. (2018). "Factors associated with clinical trials that fail and opportunities for improving the likelihood of success." (UK study of 114 trials: 31% met enrollment goals.) https://pmc.ncbi.nlm.nih.gov/articles/PMC6092479/
5. Applied Clinical Trials. "Phesi Report: Assessing Single Patient Investigator Sites in Cancer Clinical Trials." https://www.appliedclinicaltrialsonline.com/view/phesi-report-assessing-single-patient-investigator-sites-in-cancer-clinical-trials